USO1 (also known as p115) is a crucial vesicle transport factor involved in the tethering process during vesicular transport within the cell, particularly between the endoplasmic reticulum (ER) and the Golgi apparatus. It functions as a tethering factor, which means it helps to bring vesicles close to their target membrane, facilitating the fusion of vesicles with the Golgi. USO1 does this by interacting with both vesicle-associated SNAREs (v-SNAREs) and target membrane SNAREs (t-SNAREs), as well as with other Golgi-associated proteins like giantin and GM130. This protein plays a significant role in the early stages of the vesicle docking process, essential for maintaining the efficiency and specificity of intracellular transport.
Targeting USO1 (p115), a key vesicle transport factor in the ER to Golgi transport pathway, with small molecules, offers a strategic approach to dissecting the mechanisms of intracellular trafficking. By inhibiting or disrupting USO1 function, researchers can observe the direct effects on the tethering and docking of transport vesicles, which are essential steps in the vesicular transport process. Such studies can reveal the critical role of USO1 in ensuring the fidelity and efficiency of protein and lipid transport from the ER to the Golgi apparatus.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
Specifically targets the Golgi apparatus, potentially affecting the function of USO1 in vesicle tethering. | ||||||
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $69.00 $214.00 $796.00 $1918.00 | 19 | |
Affects the function of SNARE proteins and can indirectly disrupt the processes in which USO1 is involved. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
This ionophore disrupts Golgi function, which may indirectly influence USO1-mediated vesicle transport. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Affects protein glycosylation in the ER, potentially impacting the ER-Golgi transport where USO1 is involved. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Induces ER stress and can indirectly affect ER-Golgi transport, thus impacting USO1 function. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Known to affect vesicle transport and can indirectly influence SNARE-mediated processes. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubules, indirectly affecting transport to and from the Golgi apparatus. | ||||||
Ciliobrevin D | 1370554-01-0 | sc-507482 | 10 mg | $413.00 | ||
While their primary target is not the Golgi, disruption of dynein (Dynein Inhibitors) function can affect Golgi positioning and vesicle transport. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin polymerization, which can indirectly affect vesicle transport and docking. | ||||||